300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Music
Wine and Spirits
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Art
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Real Estate
Transportation
Enterprise
Community
Media (Entertainment)
Sporting Goods
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Guinea
Haiti
Croatia
Kyrgyzstan
Norway
Iran
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Luxembourg
Marshall Islands
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Kazakhstan
Switzerland
Cayman Islands
Venezuela
Myanmar
Turkey
Uruguay
Uganda
Seychelles
Moldova
Botswana
Canada
Paraguay
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Mali
United States
India
Germany
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Bulgaria
Azerbaijan
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Ecuador
Bolivia
Italy
Belize
Algeria
Hungary
Belarus
Grenada
Israel
Finland
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Chile
Ukraine
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Ciro Spedaliere, Partner at Claris Ventures

Ciro Spedaliere

Partner @ Claris Ventures

Torino, Italy

Ciro Spedaliere is a seed investor at Claris Ventures in Torino focused on Biotechnology and Health Care. Ciro Spedaliere - Partner @ Claris Ventures

Total investments:
3
Last investment:
Lead investor:
33%

Last updated:

Industries Ciro Spedaliere invests in

BiotechnologyHealth CarePharmaceuticalMedicalLife Science

Stages Ciro Spedaliere invests in

SeedSeries AVenture - Series Unknown

Countries Ciro Spedaliere invests in

Italy

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 3 (100%)
  • Health Care 2 (67%)
  • Pharmaceutical 2 (67%)
  • Medical 1 (33%)
  • Life Science 1 (33%)

Stage

  • Seed 1 (33%)
  • Series A 1 (33%)
  • Venture - Series Unknown 1 (33%)

Investments

CompanyDescriptionRoundLinks
At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need. $17.1M / Venture - Series Unknown / Apr 16, 2025
Repron Therapeutics provides treatments for solid tumor cases where radical excision is not possible and metastasis or recurrence is extremely likely. $2.1M / Seed / Jun 06, 2023
Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas. $23M / Series A / Oct 04, 2022

Co-Investors

Claris Ventures

About Claris Ventures

VC Fund · Torino, Italy

Claris Ventures is a venture capital firm focused on early-stage investments in high potential biopharma companies arisen from the Italian R&D ecosystem

Claris Ventures Contacts

NameEmailPhoneSocials
Ciro Spedaliere
Ciro Spedaliere Partner
Barbara Castellano
Barbara Castellano Investment committee member
Lola Buono
Lola Buono Senior Associate

Sign up to unlock verified contacts

Unlock Contacts

See all 3 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Music
Wine and Spirits
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Art
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Real Estate
Transportation
Enterprise
Community
Media (Entertainment)
Sporting Goods
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Guinea
Haiti
Croatia
Kyrgyzstan
Norway
Iran
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Luxembourg
Marshall Islands
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Kazakhstan
Switzerland
Cayman Islands
Venezuela
Myanmar
Turkey
Uruguay
Uganda
Seychelles
Moldova
Botswana
Canada
Paraguay
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Mali
United States
India
Germany
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Bulgaria
Azerbaijan
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Ecuador
Bolivia
Italy
Belize
Algeria
Hungary
Belarus
Grenada
Israel
Finland
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Chile
Ukraine
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Ciro Spedaliere invest in?

Ciro Spedaliere invests primarily in Biotechnology, Health Care and Pharmaceutical startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Ciro Spedaliere?

Public channels for Ciro Spedaliere include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Ciro Spedaliere last invest?

The most recent investment recorded for Ciro Spedaliere closed in Apr 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Ciro Spedaliere Ciro Spedaliere Find email